Amneal Launches Generic for Gabitril®

March 12, 2018

Bridgewater, NJ (USA), March 12, 2018 – Amneal Pharmaceuticals has launched tiagabine hydrochloride tablets in 2 mg, 4 mg, 12 mg and 16 mg strengths. The product is an AB-rated therapeutic equivalent for Gabitril®.

Tiagabine HCl tablets, available in a 30-ct bottles, are now shipping to wholesalers, distributors and direct to the trade.

Annual U.S. sales of Gabitril® and its generic equivalents were $30 million, according to January 2018 IQVIA™ market data.